DEC 05, 2017 11:39 AM PST

Scientists Finally Figure Out How Immune Cells Release IL-1

WRITTEN BY: Kara Marker

A signaling molecule called IL-1 was identified for the first time in 1984, and only now are scientists fully understanding how cells release it. From Boston Children’s Hospital, researchers describe the protein responsible for releasing IL-1 from immune cells.

Living macrophages releasing IL-1. The bright green spots are large protein complexes that stimulate gasdermin D to form pores allowing IL-1 to pass through. Credit: Charles Evavold, Boston Children's Hospital

Until now, scientists theorized that perhaps IL-1 wasn’t actively released by cells at all, that instead it was just “passively released from dead cells.” But IL-1 is indeed actively released by cells, thanks to a protein called gasdermin D. Why did it take so long to learn this about IL-1? "Most proteins have a secretion signal that causes them to leave the cell," explained senior author Jonathan Kagan, PhD. "IL-1 doesn't have that signal.”

Gasdermin D facilitates the release of IL-1 by poking holes in the cell membrane during an infection. Past studies showed gasdermin D triggering the release of other cytokines through a similar process called pyroptosis where the cell dies during the cytokine’s release. But sometimes, in the case of IL-1 release, the cell doesn’t have to die.

In 2016, some of the present study’s authors found that when dendritic cells release IL-1, they shift into a hyperactivated state, and their ability to recruit memory T cells enhances. Dendritic cells are antigen-presenting cells, which means they take pieces of foreign particles, potentially pathogens, and present them to T cells, which decide whether or not to launch an attack. In the new study, researchers experimented with hyperactivated macrophages, phagocytic cells that engulf and digest pathogens.

The new experiments showed that macrophages could also release IL-1 without dying. “Gasdermin forms enough pores to let IL-1 pass through, but not enough to kill the cell," Kagan explained.

In light of the results connecting immune cells, gastrodermin D, and the release of IL-1, boosting IL-1 release from live immune cells could be a new approach to increasing memory T cell levels. These are cells that “remember” past pathogens and are at the ready to target them again should the pathogen return.

This approach wouldn’t come without its risks, though. Researchers would have to be careful because too many inflammatory cells, a result of higher IL-1 release, can lead to autoimmune diseases; IL-1 is often a drug target for Alzheimer’s disease and inflammatory disorders.

The present study was published in the journal Immunity.

Sources: Immunology and Cell Biology, Boston Children’s Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
FEB 13, 2020
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new a ...
FEB 23, 2020
FEB 23, 2020
New discovery could help preterm babies breathe easy
Babies born more than three weeks before full term are met with complicated and often life-threatening health challenges ...
MAR 16, 2020
Drug Discovery & Development
MAR 16, 2020
Critical Interleukin Leads to Drug Discovery
The immune molecule interleukin-2 (IL-2) is a growth factor that stimulates the immune system to produce T-cells. Their ...
APR 26, 2020
APR 26, 2020
Researchers Design A Polio Vaccine That Won't Cause Polio
Sustained, intense efforts to vaccinate were getting the world very close to eradicating polio, but the vaccine itself o ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
Fecal Transplant Helps Fight off Antibiotic Resistance
Fecal transplants work by transporting fecal matter from healthy donors to those who are less healthy. Now, a study has ...
MAY 17, 2020
MAY 17, 2020
Substantial Antiviral Response Seen in Adults Recovered from COVID-19
Some good news comes as researchers scramble for potential vaccine candidates amidst the global COVID-19 pandemic. Scien ...
Loading Comments...